Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Vaspin Levels Compared With Serum Insulin and Blood Glucose Levels in Neonates

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01363622
Recruitment Status : Unknown
Verified March 2011 by Zekai Tahir Burak Women's Health Research and Education Hospital.
Recruitment status was:  Recruiting
First Posted : June 1, 2011
Last Update Posted : June 2, 2011
Sponsor:
Information provided by:
Zekai Tahir Burak Women's Health Research and Education Hospital

Brief Summary:
The aim of this study was to investigate circulating concentrations of vaspin in fetal and neonatal samples from SGA, AGA and LGA with the respective insulin concentrations. Serum vaspin concentrations were determined by enzyme immunoassay in 22 SGA and 30 LGA and 30 AGA singleton full-term fetuses and neonates on cord blood and postnatal day 5.

Condition or disease
Insulin Sensitivity

Layout table for study information
Study Type : Observational
Estimated Enrollment : 82 participants
Observational Model: Case Control
Time Perspective: Prospective
Official Title: Zekai Tahir Burak Maternity Teaching Hospital
Study Start Date : May 2010
Estimated Primary Completion Date : June 2011
Estimated Study Completion Date : July 2011

Group/Cohort
SGA
SGA (small for gestational age)
LGA
LGA (large for gestational age)
AGA
AGA (appropriate-for-gestational-age)




Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   up to 5 Days   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
SGA infant LGA infant AGA infant
Criteria

Inclusion Criteria:

  • Full term healthy infant

Exclusion Criteria:

  • sepsis
  • congenital anomaly
  • sick infant

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01363622


Contacts
Layout table for location contacts
Contact: Ahmet Akcay, MD ahmet1906ak@windowslive.com
Contact: Mehmet Yekta Öncel, MD dryekta@gmail.com

Locations
Layout table for location information
Turkey
Zekai Tahir Burak Maternity Teaching Hospital Recruiting
Ankara, Turkey, 06600
Contact: Ahmet Akcay, MD       ahmet1906ak@windowslive.com   
Sponsors and Collaborators
Zekai Tahir Burak Women's Health Research and Education Hospital
Layout table for additonal information
Responsible Party: Zekai Tahir Burak Maternity and Teaching Hospital, Ahmet Akcay
ClinicalTrials.gov Identifier: NCT01363622    
Other Study ID Numbers: ZTB061
First Posted: June 1, 2011    Key Record Dates
Last Update Posted: June 2, 2011
Last Verified: March 2011
Keywords provided by Zekai Tahir Burak Women's Health Research and Education Hospital:
Vaspin
LGA
SGA
Insulin
Blood glucose
Additional relevant MeSH terms:
Layout table for MeSH terms
Insulin Resistance
Hyperinsulinism
Glucose Metabolism Disorders
Metabolic Diseases